Literature DB >> 14748809

In defence of polypharmacy.

J K Aronson.   

Abstract

Mesh：

Year:  2004        PMID： 14748809      PMCID： PMC1884429          DOI： 10.1111/j.1365-2125.2004.02067.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  4 in total

1.  Association between antidepressant drug use and hyponatraemia: a case-control study.

Authors:  Kris L L Movig; Hubert G M Leufkens; Albert W Lenderink; Veronique G A van den Akker; Paul P G Hodiamont; Henk M J Goldschmidt; Antoine C G Egberts
Journal:  Br J Clin Pharmacol       Date:  2002-04       Impact factor: 4.335

2.  Automated signal generation in prescription-event monitoring.

Authors:  Emma Heeley; Lynda V Wilton; Saad A W Shakir
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

3.  A strategy to reduce cardiovascular disease by more than 80%.

Authors:  N J Wald; M R Law
Journal:  BMJ       Date:  2003-06-28

Review 4.  The role of oral antidiabetic agents: why and when to use an early-phase insulin secretion agent in Type II diabetes mellitus.

Authors:  E Standl; M Füchtenbusch
Journal:  Diabetologia       Date:  2002-12-18       Impact factor: 10.122
  4 in total
  19 in total

1.  Drug interactions-information, education, and the British National Formulary.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2004-04       Impact factor: 4.335

2.  Polypharmacy, appropriate and inappropriate.

Authors:  Jeffrey K Aronson
Journal:  Br J Gen Pract       Date:  2006-07       Impact factor: 5.386

3.  Medication errors: definitions and classification.

Authors:  Jeffrey K Aronson
Journal:  Br J Clin Pharmacol       Date:  2009-06       Impact factor: 4.335

Review 4.  Pharmacy interventions on prescribing in nursing homes: from evidence to practice.

Authors:  Carmel M Hughes; Kate L Lapane
Journal:  Ther Adv Drug Saf       Date:  2011-06

5.  Going beyond the numbers - a call to redefine polypharmacy.

Authors:  Carmel M Hughes; Janine A Cooper; Cristin Ryan
Journal:  Br J Clin Pharmacol       Date:  2014-06       Impact factor: 4.335

6.  Potentially inappropriate prescribing and cost outcomes for older people: a national population study.

Authors:  Caitriona Cahir; Tom Fahey; Mary Teeling; Conor Teljeur; John Feely; Kathleen Bennett
Journal:  Br J Clin Pharmacol       Date:  2010-05       Impact factor: 4.335

Review 7.  Systemic QSAR and phenotypic virtual screening: chasing butterflies in drug discovery.

Authors:  Maykel Cruz-Monteagudo; Stephan Schürer; Eduardo Tejera; Yunierkis Pérez-Castillo; José L Medina-Franco; Aminael Sánchez-Rodríguez; Fernanda Borges
Journal:  Drug Discov Today       Date:  2017-03-06       Impact factor: 7.851

8.  Beliefs about prescribed medication among older patients with polypharmacy: a mixed methods study in primary care.

Authors:  Barbara Clyne; Janine A Cooper; Fiona Boland; Carmel M Hughes; Tom Fahey; Susan M Smith
Journal:  Br J Gen Pract       Date:  2017-05-22       Impact factor: 5.386

9.  Geographical differences in the prevalence of chronic polypharmacy in older people: eleven years of the EPIFARM-Elderly Project.

Authors:  Carlotta Franchi; Massimo Cartabia; Paolo Risso; Daniela Mari; Mauro Tettamanti; Alberto Parabiaghi; Luca Pasina; Codjo Djignefa Djade; Ida Fortino; Angela Bortolotti; Luca Merlino; Alessandro Nobili
Journal:  Eur J Clin Pharmacol       Date:  2013-03-28       Impact factor: 2.953

10.  Potential drug interactions during a three-decade study period: a cross-sectional study of a prescription register.

Authors:  Emelie Astrand; Bengt Astrand; Karolina Antonov; Göran Petersson
Journal:  Eur J Clin Pharmacol       Date:  2007-06-28       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.